Bioequivalence Study of Amlodipine / Losartan/ Hydrochlorothiazide of PHARMALINE, Lebanon Under Fastion Conditions

NCT01713647 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Fasting

Interventions

DRUG: Amlodipin, losartan, HCTZ

Sponsor

Pharmaceutical Research Unit, Jordan